The Effect of Listening to Qur'an Recital on Quality of Life in Systemic Lupus Erythematosus Patients

Last updated: February 8, 2024
Sponsor: Indonesia University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Systemic Lupus Erythematosus

Lupus

Cutaneous Lupus Erythematosus

Treatment

Listening to Qur'an Recital

Clinical Study ID

NCT06263764
23-11-1954
  • Ages 18-65
  • Female
  • Accepts Healthy Volunteers

Study Summary

The goal of this quasi-experimental study is to evaluate the effect of listening to the Qur'an recital on quality of life among systemic lupus erythematosus patients. There will be intervention and control groups. Before the intervention, the quality of life of participants will be assessed using the Lupus-QoL questionnaire. After the baseline assessment, participants in the intervention group will be asked to listen to a Qur'an recital by Surah Ar-Rahman using an MP3 player twice a day for a minimum of 15 minutes each for 40 days. The control group will not receive any specific intervention and will continue with their usual routine. After the 40-day intervention period, the quality of life of participants in both groups will be assessed using the Lupus-QoL questionnaire. The results will be analyzed to determine if there is a significant improvement in quality of life. Besides, potential confounding factors such as SLE clinical manifestations, disease activity, pharmacologic treatment regimen, anxiety/depression, comorbidities, age, and economic status will also be collected before and after intervention to evaluate its effect on the quality of life.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Systemic Lupus Erythematosus Patients based on EULAR/ACR 2019 diagnostic criteria,
  • Female aged ≥ 18 years old,
  • Muslim (follower of the religion of Islam),
  • Have no auditory problems,
  • Received a steroid dose ≤ 20 mg/day equivalent to prednisone,

Exclusion

Exclusion Criteria:

  • Cannot read or write,
  • Using drugs that affect the work of the central nervous system,
  • Not willing to take part in research.

Study Design

Total Participants: 70
Treatment Group(s): 1
Primary Treatment: Listening to Qur'an Recital
Phase:
Study Start date:
February 12, 2024
Estimated Completion Date:
July 31, 2024

Study Description

Subjects who meet the eligibility criteria will be classified into intervention and control groups based on their Qur'an listening routine. Those who listen to the Qur'an less than once a week will be included in the control group. On the other hand, those who listen to the Qur'an once or more a week will be included in the intervention group. Before the intervention, we will also evaluate the potential confounding factors in each respondent that could affect quality of life, such as SLE clinical manifestations, disease activity, pharmacologic treatment regimen, anxiety or depression, comorbidities, and economic status.

Subjects in the intervention group will be asked to listen to the Al Qur'an recital (QS. Ar-Rahman) with a minimum duration of 15 minutes each, twice every day for 40 days, through an MP3 player using a headset or earphone. They will listen to the same Qur'an recital that is recited by Freed Ghalib. To ensure the respondents listen to the Qur'an recital Surah Ar-Rahman, the researcher will call and message via the Whats App application to research subjects every day for reminding. Respondents are also given a checklist card that will be filled out each time they are finished listening to the Qur'an recital. The control group will be asked not to change their habits of listening to or reading the Qur'an during this period. In addition, both the intervention and control groups will also be asked to inform the researchers if they read the Qur'an during the intervention or monitoring period.

Connect with a study center

  • Faculty of Medicine Universitas Indonesia -Cipto Mangunkusumo Hospital, Jakarta, Indonesia

    Jakarta, 10430
    Indonesia

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.